Utility of contrast-enhanced harmonic endoscopic ultrasonography for diagnosis of pancreatic tumors: a prospective multicenter study

Utility of contrast-enhanced harmonic endoscopic ultrasonography for diagnosis of pancreatic tumors: a prospective multicenter study - Utility of contrast-enhanced harmonic endoscopic ultrasonography

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011124

Enrollment

240

Registered

2013-07-20

Start date

2013-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic tumors

Interventions

Contrast-enhanced harmonic endoscopic ultrasonography

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pancreatic mass of 3cm or less to be depicted by conventional endoscopic ultrasonography Written informed consent ECOG performance status = 0-2

Exclusion criteria

Exclusion criteria: Inapropriate to perform endoscopic ultrasonography Impossible to perform endoscopy Surgically altered digestive tract Failure of other organs (ASA: Grade 3, 4) Allergy to iodine or eggs Renal failure Inability to obtain informed consent

Design outcomes

Primary

Measure	Time frame
To measure the diagnostic ability of contrast-enhanced harmonic endoscopic ultrasonography in diagnosing pancreatic tumors. To compare the diagnostic accuracy of contrast-enhanced harmonic endoscopic ultrasonography with that of tissue harmonic endoscopic ultrasonography.	—

Countries

Japan

Contacts

Public ContactShunsuke Omoto

Kindai University Faculty of Medicine gastroenterology and hepatology

shunsuke.oomoto@gmail.com072-366-0221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026